ATE399206T1 - Ribonukleoproteinkomplex aus paramyxovirus - Google Patents

Ribonukleoproteinkomplex aus paramyxovirus

Info

Publication number
ATE399206T1
ATE399206T1 AT00929790T AT00929790T ATE399206T1 AT E399206 T1 ATE399206 T1 AT E399206T1 AT 00929790 T AT00929790 T AT 00929790T AT 00929790 T AT00929790 T AT 00929790T AT E399206 T1 ATE399206 T1 AT E399206T1
Authority
AT
Austria
Prior art keywords
paramyxovirus
ribonucleoprotein complex
foreign gene
prepared
successfully
Prior art date
Application number
AT00929790T
Other languages
English (en)
Inventor
Kaio Kitazato
Tsugumine Shu
Hidekazu Kuma
Yasuji Ueda
Makoto Asakawa
Mamoru Hasegawa
Akihiro Iida
Takahiro Hirata
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of ATE399206T1 publication Critical patent/ATE399206T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18822New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT00929790T 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus ATE399206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20074099 1999-05-18

Publications (1)

Publication Number Publication Date
ATE399206T1 true ATE399206T1 (de) 2008-07-15

Family

ID=16429391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929790T ATE399206T1 (de) 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus

Country Status (12)

Country Link
EP (1) EP1179594B1 (de)
JP (1) JP3766596B2 (de)
KR (1) KR100686514B1 (de)
CN (1) CN100352925C (de)
AT (1) ATE399206T1 (de)
AU (1) AU4777900A (de)
CA (1) CA2368944C (de)
DE (1) DE60039292D1 (de)
DK (1) DK1179594T3 (de)
ES (1) ES2307509T3 (de)
HK (1) HK1044175B (de)
WO (1) WO2000070055A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070070A1 (fr) * 1999-05-18 2000-11-23 Dnavec Research Inc. Vecteur de virus paramyxoviridae defectueux dans un gene enveloppe
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
CN1418252A (zh) * 2000-01-19 2003-05-14 株式会社载体研究所 副粘病毒属载体在血管内基因转移中的用途
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
AU2002224113A1 (en) 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof
KR101279748B1 (ko) 2003-11-04 2013-07-04 가부시키가이샤 디나벡크 겐큐쇼 유전자 도입된 수상세포의 제조방법
CA2553377A1 (en) 2004-01-13 2005-07-28 Dnavec Research Inc. Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines
AU2005206410A1 (en) 2004-01-22 2005-08-04 Dnavec Research Inc. Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter
JP5296983B2 (ja) 2004-06-24 2013-09-25 株式会社ディナベック研究所 Rnaウイルスが導入された樹状細胞を含む抗癌剤
KR20080016955A (ko) 2005-06-14 2008-02-22 디나벡크 가부시키가이샤 항체의 제작방법
WO2006137517A1 (ja) * 2005-06-24 2006-12-28 Dnavec Corporation 幼少個体への遺伝子導入用ベクター
EP2993235B1 (de) 2005-10-28 2019-02-13 ID Pharma Co., Ltd. Gentransfer in epithelialen stammzellen der atemwege unter verwendung von similian lentiviralen vektoren mit senadai rna-virus-spikeprotein pseudotypisierten vektoren
CA2636600A1 (en) 2006-01-17 2007-07-26 Dnavec Corporation Novel protein expression system
WO2007139178A1 (ja) 2006-05-31 2007-12-06 Dnavec Corporation アルツハイマー病治療薬
US20100323428A1 (en) 2007-02-07 2010-12-23 Dnavec Corporation Attenuated minus-stranded rna virus
US20100203027A1 (en) 2007-04-27 2010-08-12 Kyushu Univeristy National University Viral vector for gene therapy
EP2085479A1 (de) * 2008-01-31 2009-08-05 Institut Pasteur Reverse Genetik von Negativstrang-RNA-Viren in Hefe
CA2731007A1 (en) 2008-07-16 2010-01-21 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
CN102272302B (zh) 2008-10-31 2015-04-15 生物载体株式会社 增强重组蛋白表达的方法
CN102711812B (zh) 2010-01-08 2014-07-16 国立大学法人京都大学 Tau蛋白病治疗用疫苗
CN103097521A (zh) 2010-04-16 2013-05-08 学校法人庆应义塾 人工多能性干细胞的制造方法
EP2612911B1 (de) 2010-08-30 2018-01-17 ID Pharma Co., Ltd. Zusammensetzung zur induktion pluripotenter stammzellen und ihre verwendung
JPWO2012053646A1 (ja) 2010-10-22 2014-02-24 国立大学法人北海道大学 ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム/ブーストワクチン用ウイルスベクター
CN105916980A (zh) 2013-09-24 2016-08-31 株式会社爱迪药业 用于改进诱导多能干细胞的效率的方法
CN110234347A (zh) 2016-11-17 2019-09-13 国立传染病研究所长代表日本国 使用了非感染性副粘病毒粒子的传染病疫苗
CN111479920A (zh) * 2017-07-21 2020-07-31 株式会社爱医隆集团 用于修饰靶序列的多核苷酸及其用途
EP3744847A4 (de) 2018-01-22 2021-12-08 Japan as Represented by The Director-General of National Institute of Infectious Diseases Selektives cd8-positives t-zellinduzierendes impfstoffantigen
US20230220025A1 (en) 2020-09-04 2023-07-13 Heartseed Inc. Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
EP4269571A1 (de) 2020-12-25 2023-11-01 Kyoto University Verfahren zur herstellung von naiven menschlichen ips-zellen aus somatischen zellen
WO2023053220A1 (ja) 2021-09-28 2023-04-06 公益財団法人京都大学iPS細胞研究財団 多能性幹細胞の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016171A1 (fr) * 1995-11-01 1997-05-09 Dnavec Research Inc. Liposome a membrane fusible faisant appel a un virus sendai recombinant

Also Published As

Publication number Publication date
WO2000070055A1 (fr) 2000-11-23
CN100352925C (zh) 2007-12-05
HK1044175B (zh) 2008-11-14
EP1179594A1 (de) 2002-02-13
KR20010113875A (ko) 2001-12-28
JP3766596B2 (ja) 2006-04-12
CA2368944C (en) 2010-07-27
ES2307509T3 (es) 2008-12-01
CA2368944A1 (en) 2000-11-23
AU4777900A (en) 2000-12-05
DE60039292D1 (de) 2008-08-07
EP1179594A4 (de) 2003-04-02
CN1357044A (zh) 2002-07-03
EP1179594B1 (de) 2008-06-25
KR100686514B1 (ko) 2007-02-23
DK1179594T3 (da) 2008-09-01
HK1044175A1 (en) 2002-10-11

Similar Documents

Publication Publication Date Title
ATE399206T1 (de) Ribonukleoproteinkomplex aus paramyxovirus
NO990025D0 (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
DE60038011D1 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
DE69942834D1 (de) Harnsäureoxidase
ES2155702T4 (es) Construcciones expresivas halteroformes para la terapia genetica.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ATE551421T1 (de) Rnai modulation von rsv und deren therapeutische verwendungen
DE69133228T2 (de) Dna-expressionssysteme basierend auf alphaviren
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
MXPA03004767A (es) Genes de desarollo floral.
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE450610T1 (de) Pflanzliche defensine
WO2002077158A3 (en) Root specific, stimulant inducible promoter and its use
DE502004006579D1 (de) L-carnitin dehydrogenasen, deren derivate und ein verfahren zur herstellung von substituierten (s)-alkanolen
ATE312169T1 (de) 5-aminolevulinsaure synthase aus aspergillus oryzae und dafuer kodierende nukleinsaeure
WO1999053069A3 (en) Cell cycle regulatory proteins cdc2 and pitslre from plants
DE122011100041I1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.
WO2000066743A3 (en) Viral expression vectors
DE60040077D1 (de) Vermehrungsproteine von pflanzen
ATE381625T1 (de) Hühner-rna-polymerase-i-promotor und deren verwendung
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
WO2003057824A3 (en) Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
WO1999048486A3 (en) Plant cell cyclin genes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179594

Country of ref document: EP

REN Ceased due to non-payment of the annual fee